Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Institutional buyer or Fund @ $5.50 US
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by kuatoliveson Sep 06, 2016 4:30pm
92 Views
Post# 25211414

RE:RE:RE:RE:RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 US

RE:RE:RE:RE:RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 USWhat are we looking at for valutions that would be considered overbought (after approval, assuming, of course)? Could we hit $10 (ARLZ) in the 2-3 days following a positive annoucement? I don't want to make the same mistake I made with TRX and hold too long if the market decides to overbuy on news, only to take itself down 20% waiting for earnings to catch up. I don't mind investing again, I think I should just have a firm exit point in my head here and stick to it, if the spcrosses that threshold.  After $10 ARLZ /$13 ARZ, I will start getting itchy trigger finger.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities